Clinical trial Recruiting at 1 site Observational Ages 5 to 17

Urinary PGE-M to help predict acute appendicitis in children

Official title: Prostaglandin-E Urinary Metabolite (PGE-M) as a Predictor of Acute Appendicitis in Children

Run by KBC Split · NCT07008092 · Data updated 2026-11-12

We will test whether a urine marker called PGE-M can help diagnose acute appendicitis in children ages 5 to 17 who come in with sudden belly pain.

Quick facts

Study typeObservational
Ages5 Years to 17 Years
SexAll
Enrollment100 (estimated)
SponsorKBC Split
Academic / other
Locations1 site (Split)
StatusRecruiting
StartedJune 2, 2025
Main results expectedMay 1, 2026
Study endsMay 1, 2026
Registry record updatedJune 6, 2025
Trial IDNCT07008092 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 5 to 17 who present with acute abdominal pain and clinical signs suggestive of acute appendicitis and who do not have significant comorbidities qualify for this study.

Probably not a fit

Children outside the 5–17 age range, those with prior abdominal surgery, chronic or malignant disease, pregnancy, or whose pain is clearly due to another diagnosis are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a 12-month observational study enrolling about 100 children aged 5–17 who present with acute abdominal pain and signs suggestive of appendicitis at the University Hospital of Split. Participants will have routine labs and a urine sample collected to measure prostaglandin E urinary metabolite (PGE-M) levels, with clinical course, imaging, surgical findings, and final diagnosis recorded. Investigators will compare PGE-M levels between children with confirmed appendicitis and those with other causes of abdominal pain to see if PGE-M is higher in appendicitis. The study involves minimal additional risk because urine and routine blood samples are collected as part of care.

Why it matters

Potential benefit: If successful, using urinary PGE-M could help doctors diagnose appendicitis faster and more accurately, reducing missed cases and unnecessary surgeries.

How similar studies have gone: PGE-M has been reported elevated in other inflammatory conditions, but using urinary PGE-M to diagnose pediatric appendicitis is relatively novel and not yet well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* children of age 5 -17 years with acute abdominal pain
* children with clinical signs of acute appendicitis

Exclusion Criteria:

* previous diagnosis of chronic and/or malignant disease
* children who had previous abdominal surgery
* pregnancy

Where it's running

  • University Hospital of Split
    Split, Croatia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.